A molecular genetic diagnosis of LS is established by identifying either a germline pathogenic variant in one of the DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6 or PMS2 or an EPCAM deletion affecting the expression of MSH23. This evidence concerns the gene MLH1 and Leigh syndrome.